GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Covalon Technologies Ltd (OTCPK:CVALF) » Definitions » 5-Year ROIIC %

Covalon Technologies (Covalon Technologies) 5-Year ROIIC % : -287.65% (As of Sep. 2023)


View and export this data going back to 2007. Start your Free Trial

What is Covalon Technologies 5-Year ROIIC %?

5-Year Return on Invested Incremental Capital (5-Year ROIIC %) measures the change in earnings as a percentage of change in investment over 5-year. Covalon Technologies's 5-Year ROIIC % for the quarter that ended in Sep. 2023 was -287.65%. High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.

The industry rank for Covalon Technologies's 5-Year ROIIC % or its related term are showing as below:

CVALF's 5-Year ROIIC % is ranked worse than
82.92% of 1382 companies
in the Biotechnology industry
Industry Median: -19.695 vs CVALF: -287.65

Covalon Technologies 5-Year ROIIC % Historical Data

The historical data trend for Covalon Technologies's 5-Year ROIIC % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Covalon Technologies 5-Year ROIIC % Chart

Covalon Technologies Annual Data
Trend Sep14 Sep15 Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23
5-Year ROIIC %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -40.63 -19.44 38.37 -153.72 -287.65

Covalon Technologies Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
5-Year ROIIC % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - -287.65 -

Competitive Comparison of Covalon Technologies's 5-Year ROIIC %

For the Biotechnology subindustry, Covalon Technologies's 5-Year ROIIC %, along with its competitors' market caps and 5-Year ROIIC % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Covalon Technologies's 5-Year ROIIC % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Covalon Technologies's 5-Year ROIIC % distribution charts can be found below:

* The bar in red indicates where Covalon Technologies's 5-Year ROIIC % falls into.



Covalon Technologies 5-Year ROIIC % Calculation

Covalon Technologies's 5-Year ROIIC % for the quarter that ended in Sep. 2023 is calculated as:

5-Year ROIIC %=5-Year Incremental Net Operating Profit After Taxes (NOPAT)**/5-Year Incremental Invested Capital**
=( -3.347 (Sep. 2023) - 1.241 (Sep. 2018) )/( 8.603 (Sep. 2023) - 7.291 (Sep. 2018) )
=-4.588/1.312
=-349.70%***

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** Annual data of NOPAT and Invested Capital was used to calculate 5-Year ROIIC %.
*** Please be aware that the ROIIC (Return on Invested Capital) calculations are based on company-level data using the primary share class. The calculated data provided is for demonstration purposes and may slightly differ from the results displayed in the title due to potential variations caused by currency exchange rate differences throughout the year.


Covalon Technologies  (OTCPK:CVALF) 5-Year ROIIC % Explanation

Return on Incremental Invested Capital (ROIIC) is an extension of Return on Investment Capital (ROIC). ROIC % tells investors how efficiently that profitability is earned per dollar of company capital. ROIIC narrows the focus even further and shows how profitable each additional unit of capital investment could be. ROIIC % is a more powerful metric than ROIC because it measures how much money the company can generate going forward on future capital investments.

High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.

Be Aware

It's important to keep in mind that when tracking ROIIC, the metric is better suited to forecasting the trend of future returns rather than measuring current return on investment.


Covalon Technologies 5-Year ROIIC % Related Terms

Thank you for viewing the detailed overview of Covalon Technologies's 5-Year ROIIC % provided by GuruFocus.com. Please click on the following links to see related term pages.


Covalon Technologies (Covalon Technologies) Business Description

Traded in Other Exchanges
Address
1660 Tech Avenue, Unit 5, Mississauga, ON, CAN, L4W 5S7
Covalon Technologies Ltd is principally engaged in the business of developing, licensing, and selling medical technologies. The company develops advanced wound care line which is designed for the treatment of a wide range of wounds; and infection prevention products such as MediClear PreOp which is a breathable, transparent, self-adhesive silicone barrier film that conforms to the contours of the body. It also develops perioperative care products. The company generates its revenue through development contracts, licensing agreements, and distribution contracts, and sales.

Covalon Technologies (Covalon Technologies) Headlines

From GuruFocus

Covalon Enters into Automatic Share Purchase Plan

By PRNewswire PRNewswire 06-30-2022